Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mansky

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|August 7, 2023
Unconventional stabilization of the human T-cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1Christine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineChristine L Clouser, Jay Chauhan, Matthew A Bess, et al.
Journal of Molecular Biology|May 1, 2022
Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for AssemblyDominik Herrmann, Heather M Hanson, Lynne W Zhou, et al.
Nature Structural & Molecular Biology|September 6, 2024
Distinct stabilization of the human T cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Retrovirology|March 25, 2016
Dual anti-HIV mechanism of clofarabineMichele B Daly, Megan E Roth, Laurent Bonnac, et al.
Bioorganic & Medicinal Chemistry|October 15, 2013
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitorsJonathan M Rawson, Richard H Heineman, Lauren B Beach, et al.
Retrovirology|September 22, 2010
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometryIwen F Grigsby, Wei Zhang, Jolene L Johnson, et al.
Plos One|January 26, 2011
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineChristine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Journal of Virology|April 27, 2018
Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle AssemblyJessica L Martin, Luiza M Mendonça, Rachel Marusinec, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|August 7, 2023
Unconventional stabilization of the human T-cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2012
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1Christine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineChristine L Clouser, Jay Chauhan, Matthew A Bess, et al.
Journal of Molecular Biology|May 1, 2022
Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for AssemblyDominik Herrmann, Heather M Hanson, Lynne W Zhou, et al.
Nature Structural & Molecular Biology|September 6, 2024
Distinct stabilization of the human T cell leukemia virus type 1 immature Gag latticeMartin Obr, Mathias Percipalle, Darya Chernikova, et al.
Retrovirology|March 25, 2016
Dual anti-HIV mechanism of clofarabineMichele B Daly, Megan E Roth, Laurent Bonnac, et al.
Bioorganic & Medicinal Chemistry|October 15, 2013
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitorsJonathan M Rawson, Richard H Heineman, Lauren B Beach, et al.
Retrovirology|September 22, 2010
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometryIwen F Grigsby, Wei Zhang, Jolene L Johnson, et al.
Plos One|January 26, 2011
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineChristine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Journal of Virology|April 27, 2018
Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle AssemblyJessica L Martin, Luiza M Mendonça, Rachel Marusinec, et al.
Pageof 13